Back to Agenda
Session 7: The IND in Detail - Additional Topics
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Additional Requirements for Biologics and Biotechnology-derived Products
- Assembly and Submission of an Original IND
Have an account?